Biostate AI, a cutting-edge artificial intelligence company specializing in RNA sequencing, has announced a strategic partnership with the Accelerated Cure Project (ACP), a nonprofit focused on improving outcomes for people with multiple sclerosis (MS). The collaboration aims to build next-generation AI models capable of predicting disease progression and treatment response, leveraging transcriptomic data from ACP’s vast MS biorepository. This partnership represents a landmark move at the intersection of AI, precision medicine, and neuroimmunology, with the potential to fundamentally reshape how MS is diagnosed, monitored, and treated. Read More
                                
    







